Nearly half of seniors quit GLP-1 weight-loss drugs within a year. Experts reveal why older Americans abandon medications ...

Low-income Californians who use Wegovy and similar weight loss drugs will lose their coverage in January. California and ...

SaveHealth reports on managing type 2 diabetes through medications, lifestyle changes, and support, highlighting various ...

NPPA fixed prices of 37 new drug formulations under DPCO 2013, covering diabetes, hypertension, respiratory and mental health ...

New research finds statins benefit adults with type 2 diabetes across all heart-risk levels, reducing deaths and serious ...

Drugs like Ozempic, Wegovy and Zepbound have transformed how we treat obesity, but more effective treatments could be down ...

Sun Pharma highlights obesity treatment drugs as a growth driver for India's pharma industry, enhancing access to GLP-1 ...

A cheap diabetes drug is currently being assessed for its potential to halt the progression of a life-threatening condition.

The study also found that women with a history of GLP-1 use had a 30% higher risk of developing gestational diabetes, a ...

Obesity treatment drugs to drive pharma industry growth in India. Sun Pharma highlights GLP-1 impact. Innovation & ...

To begin to close the equity gap in diabetes, we must commit to designing therapies that account for the practical realities ...

The drugs' high prices, along with spotty insurance coverage, have left them out of reach for many Americans. Read more at ...